J M Polinski

Summary

Affiliation: Massachusetts General Hospital
Country: USA

Publications

  1. ncbi request reprint Patterns and trends in insulin intensification among patients with type 2 diabetes: A systematic review
    Jennifer M Polinski
    Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women s Hospital, Boston, MA, United States Harvard Medical School, Boston, MA, United States Electronic address
    Prim Care Diabetes 8:101-9. 2014
  2. doi request reprint Barriers to insulin progression among patients with type 2 diabetes: a systematic review
    Jennifer M Polinski
    Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women s Hospital, 1620 Tremont Street, Suite 3030, Boston, MA 02120, USA
    Diabetes Educ 39:53-65. 2013
  3. pmc Rationale and design of the multinational observational study assessing insulin use: the MOSAIc study
    Jennifer M Polinski
    Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women s Hospital, 1620 Tremont Street, Suite 3030, Boston, MA, USA
    BMC Endocr Disord 12:20. 2012
  4. pmc Beneficiaries with cardiovascular disease and thePart D coverage gap
    Jennifer M Polinski
    Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women s Hospital, Boston, MA 02120, USA
    Circ Cardiovasc Qual Outcomes 5:387-95. 2012
  5. pmc Confronting "confounding by health system use" in Medicare Part D: comparative effectiveness of propensity score approaches to confounding adjustment
    Jennifer M Polinski
    Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women s Hospital, Boston, MA, USA
    Pharmacoepidemiol Drug Saf 21:90-8. 2012
  6. pmc Medicare part D's impact on antipsychotic drug use and costs among elderly patients without prior drug insurance
    Jennifer M Polinski
    Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women s Hospital, Boston, MA 02120, USA
    J Clin Psychopharmacol 32:3-10. 2012
  7. pmc Validation of rheumatoid arthritis diagnoses in health care utilization data
    Seo Young Kim
    Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women s Hospital Harvard Medical School, 75 Francis Street, Boston, MA 02115, USA
    Arthritis Res Ther 13:R32. 2011
  8. pmc Medicare beneficiaries' knowledge of and choices regarding Part D, 2005 to the present
    Jennifer M Polinski
    Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women s Hospital, Boston, Massachusetts 02120, USA
    J Am Geriatr Soc 58:950-66. 2010
  9. doi request reprint Where cost, medical necessity, and morality meet: should US government insurance programs pay for erectile dysfunction drugs?
    J M Polinski
    Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women s Hospital and Harvard Medical School, Boston, Massachusetts, USA
    Clin Pharmacol Ther 89:17-9. 2011
  10. pmc Time series evaluation of an intervention to increase statin tablet splitting by general practitioners
    Jennifer M Polinski
    Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women s Hospital, Boston, Massachusetts 02120, USA
    Clin Ther 33:235-43. 2011

Detail Information

Publications33

  1. ncbi request reprint Patterns and trends in insulin intensification among patients with type 2 diabetes: A systematic review
    Jennifer M Polinski
    Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women s Hospital, Boston, MA, United States Harvard Medical School, Boston, MA, United States Electronic address
    Prim Care Diabetes 8:101-9. 2014
    ..The paucity of available studies prevented a comprehensive understanding of patterns and trends in insulin intensification. Such information is needed to assess the quality of pharmacologic care for patients with T2DM. ..
  2. doi request reprint Barriers to insulin progression among patients with type 2 diabetes: a systematic review
    Jennifer M Polinski
    Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women s Hospital, 1620 Tremont Street, Suite 3030, Boston, MA 02120, USA
    Diabetes Educ 39:53-65. 2013
    ..progression among patients with type 2 diabetes: (1) What are the patient, provider, and health system barriers to insulin progression? (2) Do insulin progression barriers differ between insulin-naive and insulin-experienced patients?..
  3. pmc Rationale and design of the multinational observational study assessing insulin use: the MOSAIc study
    Jennifer M Polinski
    Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women s Hospital, 1620 Tremont Street, Suite 3030, Boston, MA, USA
    BMC Endocr Disord 12:20. 2012
    ..abstract:..
  4. pmc Beneficiaries with cardiovascular disease and thePart D coverage gap
    Jennifer M Polinski
    Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women s Hospital, Boston, MA 02120, USA
    Circ Cardiovasc Qual Outcomes 5:387-95. 2012
    ..The coverage gap remains the subject of Congressional debate; evidence regarding its impact on cardiovascular drug use and health outcomes is needed...
  5. pmc Confronting "confounding by health system use" in Medicare Part D: comparative effectiveness of propensity score approaches to confounding adjustment
    Jennifer M Polinski
    Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women s Hospital, Boston, MA, USA
    Pharmacoepidemiol Drug Saf 21:90-8. 2012
    ....
  6. pmc Medicare part D's impact on antipsychotic drug use and costs among elderly patients without prior drug insurance
    Jennifer M Polinski
    Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women s Hospital, Boston, MA 02120, USA
    J Clin Psychopharmacol 32:3-10. 2012
    ..Part D implementation was associated with increased use and affordability of APMs for the elderly without prior drug insurance...
  7. pmc Validation of rheumatoid arthritis diagnoses in health care utilization data
    Seo Young Kim
    Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women s Hospital Harvard Medical School, 75 Francis Street, Boston, MA 02115, USA
    Arthritis Res Ther 13:R32. 2011
    ..Health care utilization databases have been increasingly used for studies of rheumatoid arthritis (RA). However, the accuracy of RA diagnoses in these data has been inconsistent...
  8. pmc Medicare beneficiaries' knowledge of and choices regarding Part D, 2005 to the present
    Jennifer M Polinski
    Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women s Hospital, Boston, Massachusetts 02120, USA
    J Am Geriatr Soc 58:950-66. 2010
    ..Beneficiaries' knowledge and choices should be monitored on an ongoing basis to inform potential changes to the Part D program...
  9. doi request reprint Where cost, medical necessity, and morality meet: should US government insurance programs pay for erectile dysfunction drugs?
    J M Polinski
    Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women s Hospital and Harvard Medical School, Boston, Massachusetts, USA
    Clin Pharmacol Ther 89:17-9. 2011
    ..We conclude that the clinical usefulness and costs of such drugs should be the primary drivers of coverage decisions, not moral attitudes toward sexual performance...
  10. pmc Time series evaluation of an intervention to increase statin tablet splitting by general practitioners
    Jennifer M Polinski
    Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women s Hospital, Boston, Massachusetts 02120, USA
    Clin Ther 33:235-43. 2011
    ..Statins can be split safely. General practitioners (GPs) may not direct their patients to split statins because of safety concerns or unawareness of costs. Medical chart inserts provide cost-effective education to physicians...
  11. pmc High-risk patients' readiness to undergo BMD testing for osteoporosis diagnosis in Pennsylvania
    Jennifer M Polinski
    Brigham and Women s Hospital, Boston, Massachusetts, USA
    Int Q Community Health Educ 29:223-40. 2008
    ..We found several correlates of readiness to undergo BMD screening that may be used to design effective interventions...
  12. pmc Does knowledge of medication prices predict physicians' support for cost effective prescribing policies
    Jennifer M Polinski
    Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women s Hospital, Boston, MA, USA
    Can J Clin Pharmacol 15:e286-94. 2008
    ..Years after implementation, these policies remain controversial among physicians...
  13. pmc Changes in drug utilization during a gap in insurance coverage: an examination of the medicare Part D coverage gap
    Jennifer M Polinski
    Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women s Hospital, Boston, Massachusetts, United States of America
    PLoS Med 8:e1001075. 2011
    ..While increased discontinuation of and adherence to essential medications is a regrettable response, increased switching to less expensive but therapeutically interchangeable medications is a positive response to minimize costs...
  14. ncbi request reprint Educational outreach (academic detailing) regarding osteoporosis in primary care
    Jennifer M Polinski
    Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women s Hospital, Harvard Medical School, Boston, MA 02120, USA
    Pharmacoepidemiol Drug Saf 14:843-50. 2005
    ..Academic detailing programs have improved physician's prescribing behaviors; however, the feasibility of large-scale programs across a large, geographically disperse state is unclear...
  15. ncbi request reprint Medicaid's prior authorization program and access to atypical antipsychotic medications
    Jennifer M Polinski
    Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women s Hospital, Boston, Massachusetts, USA
    Health Aff (Millwood) 26:750-60. 2007
    ..More than a year later, no state had changed its PA policy in response. We discuss the roles of Medicaid and other insurers in responding to emerging drug safety issues and their challenges in weighing drug risks and benefits...
  16. ncbi request reprint Interactive voice response telephone calls to enhance bone mineral density testing
    Jennifer M Polinski
    Division of Pharmacoepidemiology and Pharmacoeconomics, 1620 Tremont St, Ste 3030, Boston, MA 02120, USA
    Am J Manag Care 12:321-5. 2006
    ..Bone mineral density (BMD) testing is a key tool used to diagnose and treat osteoporosis. We assessed the rate of scheduling BMD tests among health plan members at risk for osteoporosis who received interactive voice response (IVR) calls...
  17. pmc Completeness of retail pharmacy claims data: implications for pharmacoepidemiologic studies and pharmacy practice in elderly patients
    Jennifer M Polinski
    Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women s Hospital, Boston, Massachusetts 02120, USA
    Clin Ther 31:2048-59. 2009
    ..Claims include only prescriptions filled at 1 pharmacy location or within 1 pharmacy chain and do not include prescriptions filled at outside pharmacies, potentially limiting research accuracy and pharmacy-based safety interventions...
  18. pmc Changes in drug use and out-of-pocket costs associated with Medicare Part D implementation: a systematic review
    Jennifer M Polinski
    Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women s Hospital, Boston, Massachusetts, USA
    J Am Geriatr Soc 58:1764-79. 2010
    ..The effect of the Part D transition period remains unclear. Although public-use data will validate these results, policymakers can use the existing evidence to inform changes and enhancements to Part D immediately...
  19. pmc Medicare Part D's effect on the under- and overuse of medications: a systematic review
    Jennifer M Polinski
    Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women s Hospital, Boston, Massachusetts 02120, USA
    J Am Geriatr Soc 59:1922-33. 2011
    ..To evaluate the literature regarding the effect of Medicare Part D on the under- and overuse of specific medications and corresponding health outcomes...
  20. ncbi request reprint Gaps in treatment among users of osteoporosis medications: the dynamics of noncompliance
    M Alan Brookhart
    Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women s Hospital Harvard Medical School, Boston, Mass 02120, USA
    Am J Med 120:251-6. 2007
    ..We sought to estimate the percentage of patients who restart osteoporosis therapy after a prolonged lapse in medication use and to identify the factors associated with a return to compliance...
  21. ncbi request reprint Access to bone mineral density testing in patients at risk for osteoporosis
    D H Solomon
    Division of Pharmacoepidemiology, Brigham and Women s Hospital, 1620 Tremont Street, Suite 3030, Boston, MA 02120, USA
    Osteoporos Int 17:1749-54. 2006
    ..We assessed whether access to bone mineral density (BMD) testing was a predictor of osteoporosis management in an at-risk population of patients from New Jersey...
  22. pmc Adherence to osteoporosis medications after patient and physician brief education: post hoc analysis of a randomized controlled trial
    Aimee Der Huey Shu
    Division of Pharmacoepidemiology, Brigham and Women s Hospital, MA 02115, USA
    Am J Manag Care 15:417-24. 2009
    ..To examine whether adherence to osteoporosis medications can be improved by educational interventions targeted at primary care physicians (PCPs) and patients...
  23. ncbi request reprint Compliance with osteoporosis medications
    Daniel H Solomon
    Divisions of Pharmacoepidemiology, Brigham and Women s Hospital, Boston, MA 02120, USA
    Arch Intern Med 165:2414-9. 2005
    ..This study was undertaken to assess the level and determinants of compliance with drugs prescribed for osteoporosis...
  24. ncbi request reprint Restrictions on antidepressant medications for children: a review of Medicaid policy
    Michael A Fischer
    Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women s Hospital, 1620 Tremont St, Suite 3030, Boston, MA 02120, USA
    Psychiatr Serv 58:135-8. 2007
    ..This study evaluated Medicaid's prior-authorization policies restricting the prescribing of antidepressant medications for children...
  25. pmc Improving care of patients at-risk for osteoporosis: a randomized controlled trial
    Daniel H Solomon
    Division of Pharmacepidemiology, Brigham and Women s Hospital, Boston, MA 02120, USA
    J Gen Intern Med 22:362-7. 2007
    ..We tested the effectiveness of an intervention to improve care in patients at-risk of osteoporosis...
  26. ncbi request reprint Osteoporosis improvement: a large-scale randomized controlled trial of patient and primary care physician education
    Daniel H Solomon
    Division of Pharmacoepidemiology, Department of Medicine, Brigham and Women s Hospital, Boston, Massachusetts, USA
    J Bone Miner Res 22:1808-15. 2007
    ..04; 95% ci, 0.85-1.26)...
  27. ncbi request reprint Quality indicators for medication use in vulnerable elders
    William H Shrank
    Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women s Hospital, Boston, MA 02120, USA
    J Am Geriatr Soc 55:S373-82. 2007
  28. pmc Prior authorization for biologic disease-modifying antirheumatic drugs: a description of US Medicaid programs
    Michael A Fischer
    Brigham and Women s Hospital, Harvard Medical School, Boston, Massachusetts 02120, USA
    Arthritis Rheum 59:1611-7. 2008
    ..To evaluate state Medicaid prior authorization programs for biologic disease-modifying antirheumatic drugs (DMARDs)...
  29. pmc Comparison of prospective and retrospective indicators of the quality of end-of-life cancer care
    Soko Setoguchi
    Division of General Medicine and Primary Care, Brigham and Women s Hospital, Boston, MA 02120 1613, USA
    J Clin Oncol 26:5671-8. 2008
    ..To compare prospectively and retrospectively defined benchmarks for the quality of end-of-life care, including a novel indicator for the use of opiate analgesia...
  30. doi request reprint Impact of Medicare Part D on access to and cost sharing for specialty biologic medications for beneficiaries with rheumatoid arthritis
    Jennifer M Polinski
    Brigham and Women s Hospital, Boston, Massachusetts 02120, USA
    Arthritis Rheum 61:745-54. 2009
    ..To date, no one has examined the cost-sharing structures for biologic DMARDs in Part D plans or the resulting cost burden for patients...
  31. ncbi request reprint A randomized controlled trial of mailed osteoporosis education to older adults
    D H Solomon
    Division of Pharmacoepidemiology, Brigham and Women s Hospital, Harvard Medical School, 1620 Tremont Street, Suite 3030, Boston, MA 02120, USA
    Osteoporos Int 17:760-7. 2006
    ..The setting was a large publicly funded state pharmacy benefits program. The patients were 31,715 Medicare beneficiaries from Pennsylvania who participated in a drug benefits program for low-to-moderate income elderly people...
  32. ncbi request reprint Older adults' knowledge and beliefs about osteoporosis: results of semistructured interviews used for the development of educational materials
    Michele Burgener
    Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women s Hospital, Harvard Medical School, Boston, Massachusetts 02120, USA
    J Rheumatol 32:673-7. 2005
    ..These messages will be used as part of a trial that will test the efficacy of both public and doctor education to improve osteoporosis management...
  33. pmc The effect of transitioning to medicare part d drug coverage in seniors dually eligible for medicare and medicaid
    William H Shrank
    Department of Medicine, Division of Pharmacoepidemiology, Brigham and Women s Hospital, Harvard Medical School, Boston, Massachusetts 02120, USA
    J Am Geriatr Soc 56:2304-10. 2008
    ..To evaluate medication use, out-of-pocket spending, and medication switching during the transition period for patients dually eligible for Medicaid and Medicare (dual eligibles)...